02-11-2022

The firm is expanding its global distribution, generating innovation and new products to broaden the Company’s product portfolio to become the world’s circulatory support leader.

Farmington, MI – June, 2022 –

The CEO Views has identified PulseCath, a disruptor in the medical device market as one of the top 10 Healthcare Companies of the Year 2022.

The firm’s unique and proprietary platform offers short-term circulatory support system to help cardiologists and cardiac surgeons address a wide range of patient’s issues. PulseCath has been instrumental in delivering early cardiac institutional support, non-invasive methods, and other great list of innovations in the medical device production and manufacturing arena thus reducing healthcare costs and improving patient outcomes.

“It’s a great honor to announce PulseCath as one of the top 10 Healthcare Companies of the Year 2022,” said Ben Johnson, Managing Editor of The CEO Views.

PulseCath is focused on developing ground-breaking technologies designed to assist the life sustaining pumping functions of the failing heart.

CEO Views
Published from Farmington Hills, Michigan, The CEO Views is a print and digital magazine that aims towards providing the perfect platform for entrepreneurs to connect with the industry peers while exploring and understanding innovations that are changing the technology landscape of today and moving towards a newer world.

Please check also the interview online via this link.